Notes to SEFA
Title: Note 1. Basis of Presentation
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
De Minimis Rate Used: Y
Rate Explanation: The Corporation has elected to use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance.
The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award
activity of Parkview Health System, Inc. d/b/a Parkview Health, Parkview Hospital Inc., and Subsidiaries
(collectively, the Corporation) under programs of the federal government for the year ended
December 31, 2023. The information in this Schedule is presented in accordance with the requirements
of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost
Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule
presents only a selected portion of the operations of the Corporation, it is not intended to and does not
present the financial position, changes in net assets, or cash flows of the Corporation.
Title: Note 4. Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution
Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
De Minimis Rate Used: Y
Rate Explanation: The Corporation has elected to use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance.
During the year ended December 31, 2022, the Corporation received amounts from the U.S. Department of Health and Human Services (HHS) through the Provider Relief Fund and American Rescue (ARP) Rural Distribution (Assistance Listing number 93.498). In accordance with HHS guidance, this funding was included on the Schedule for the year ended December 31, 2023. The Schedule reflects distributions in the amount of $59,428 received by the Corporation during the year ended December 31, 2023, which were reported by the entities as follows: